The first successful IUD and transcervical procedures using Aspivix’s non-traumatic Carevix were performed in the U.S. This milestone underscores the potential of Carevix to offer a gentler alternative to traditional methods. The procedures were performed by Alissa M. Conklin, MD., Assistant Professor of Clinical Obstetrics and Gynecology at Indiana University School of Medicine. She shared: “The suction was perfectly adequate and easy…
Dandi, a platform dedicated to improving the fertility care journey, has raised $1.3 million in funding from investors including Tiferes Ventures, Ruttenberg Gordon Investments, Winklevoss Capital, and the WeWork Alumni Fund. The funding round aims to bolster Dandi’s offerings and expand its reach in supporting individuals facing fertility challenges. With infertility on the rise, Dandi recognizes the need to address the multifaceted…
Gilead Sciences has announced that the U.S. Food and Drug Administration (FDA) has approved an updated label for Biktarvy. This approval includes additional data supporting the safety and efficacy of Biktarvy for pregnant individuals living with HIV-1 (PWH) who have suppressed viral loads. Biktarvy is a complete HIV treatment that combines three powerful medicines to form the smallest 3-drug, integrase strand transfer…
Gynoveda, an Indian Ayurveda fertility company, has opened its second fertility clinic in Pune, underscoring its commitment to empowering couples on their journey to parenthood. With a goal to impact the lives of 10 million couples across India, this expansion signifies a significant step forward for the company. Gynoveda is known for its blend of Ayurveda, technology, content, and community, and offers…
Testmate Health, a startup focused on sexual health diagnostics, has successfully raised $6 million in seed funding to revolutionize STI testing. The funding round, led by RH Capital with participation from The Helm, Amboy Street Ventures, Liechtsteiner Foundation, Zürcher Kantonal Bank and Dartlabs.io, marks a significant milestone for Testmate’s mission to improve access to essential diagnostics while ensuring accuracy and privacy. Unlike…
Germany-based Ovom Care has raised €4.8 million in seed funding led by Alpha Intelligence Capital and supported by Ananda Impact Ventures and Merantix. The company combines hybrid reproductive care with advanced AI solutions, aiming to improve patient outcomes and expand fertility access to women at more affordable rates. To date Ovom Care has treated over 100 patients in its London clinic and…
Proov, the creator of a suite of at-home fertility-related hormone tests, has announced today that an equity share of the company has been purchased by GRAMMY award-winning singer-songwriter, actor and author Ashanti and her fiancé, GRAMMY winning, Double Diamond selling, entertainment icon Nelly. This newscomes off of the duo’s pregnancy announcement via Instagram last week, which featured the Proov Check test. Proov…
Stork Club Reproductive Care has achieved a significant milestone, extending its reach to 100 countries globally and providing access to over 8,000 in-network providers. The company has also introduced an innovative Direct Pay system, simplifying the member experience by eliminating the need for virtual benefits cards. This expansion of Stork Club, an enterprise reproductive care benefits solution, ensures that critical reproductive and…
